Harneys advises Global Brain and TOHO HOLDINGS on launch of TOHO Ventures
TOHO HOLDINGS is a leading Japanese corporate group that supports medical institutions and pharmacies through pharmaceutical wholesale, dispensing pharmacy operations, and drug manufacturing. In response to transformative changes in healthcare, TOHO HOLDINGS launched TOHO Ventures to collaborate with innovative startups and drive the next wave of advancements in medicine.
The fund focuses on investing in pioneering drug discovery and biotechnology startups, particularly those based outside Japan. It supports cutting-edge platforms that enhance drug development efficiency through AI, data science, and breakthroughs in cellular and genetic engineering. Beyond capital, TOHO Ventures leverages TOHO HOLDINGS’ extensive assets, including its distribution network and manufacturing infrastructure, to help startups achieve commercialisation.
The Harneys team was led by Partner Yucheng Fan, with support from Associate Julia Xie. Speaking about the deal, Yucheng said: “We are pleased to have supported the launch of TOHO Ventures. This initiative brings together healthcare and innovation, and we are proud to have contributed our legal expertise to facilitate its establishment. We look forward to seeing TOHO Ventures’ role in advancing progress within the healthcare sector.”
Harneys’ Investment Funds team advises on all aspects of the life of a BVI, Cayman, Cyprus, or Luxembourg fund, including formation, restructuring, and closure, both in distressed and planned scenarios. The firm’s funds lawyers sit side-by-side with the funds team from its strategic alliance partner,Harneys Fiduciary, allowing Harneys to provide integrated legal and administrative support to its funds clients.


